Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zivo Bioscience Inc (ZIVO)
OTHER OTC:ZIVO
Holding ZIVO?
Track your performance easily
ZIVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.48 - $13.38
Previous Close$8.45
Volume1.39K
Average Volume (3M)1.22K
Market Cap
$23.93M
Enterprise Value$25.43M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.50M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Mar 15, 2024EPS Estimate
-$0.91Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.79
Shares Outstanding2,831,943
10 Day Avg. Volume945
30 Day Avg. Volume1,224
Standard Deviation0.79
R-Squared0.00022
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-20.90
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.60K
Enterprise Value/Gross Profit-22.01
Enterprise Value/Ebitda-3.20
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Zivo Bioscience News
PremiumCompany Announcements
Zivo Bioscience Strengthens Board with New Director Appointment
PremiumCompany Announcements
Zivo Bioscience Enhances Equity Incentive Plans for Leadership
Bulls Say, Bears Say
Bulls Say
EarningsZIVO reported 1Q24 results with revenue above estimates, operating expenses below, and a narrower GAAP loss per share.
Product BenefitsZIVO's product candidate for poultry feed reduces intestinal damage and optimizes feed utilization in broiler chickens.
Product DevelopmentA major global animal health company is scheduled to begin confirmatory studies on ZIVO's novel immune-modulating biologic poultry feed product candidate.
Bears Say
Capital ConstraintsZIVO had cash and equivalents of $140K and debt of $0.7M, and is expected to burn an average of $1.3M per quarter through 2024, relying primarily on private offerings, a regulation A offering, or high interest loans for capital.
Financial PerformanceZIVO reported revenue below estimates, with operating expenses above expectations and a wider GAAP loss-per-share.
Potential AgreementsThere is a risk that a development and licensing deal does not come to fruition, and even if signed, it may not address concerns regarding the balance sheet and access to capital.
---
Ownership Overview
48.96% Insiders
13.46% Mutual Funds
0.01% Other Institutional Investors
37.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ZIVO FAQ
What was Zivo Bioscience Inc’s price range in the past 12 months?
Zivo Bioscience Inc lowest stock price was $0.48 and its highest was $13.38 in the past 12 months.
What is Zivo Bioscience Inc’s market cap?
Currently, no data Available
When is Zivo Bioscience Inc’s upcoming earnings report date?
Zivo Bioscience Inc’s upcoming earnings report date is Mar 15, 2024 which is 251 days ago.
How were Zivo Bioscience Inc’s earnings last quarter?
Zivo Bioscience Inc released its earnings results on Nov 13, 2023. The company reported -$1.05 earnings per share for the quarter, the consensus estimate of -$1.05 by $0.
Is Zivo Bioscience Inc overvalued?
According to Wall Street analysts Zivo Bioscience Inc’s price is currently Overvalued.
Does Zivo Bioscience Inc pay dividends?
Zivo Bioscience Inc does not currently pay dividends.
What is Zivo Bioscience Inc’s EPS estimate?
Zivo Bioscience Inc’s EPS estimate is -$0.91.
How many shares outstanding does Zivo Bioscience Inc have?
Zivo Bioscience Inc has 2,831,943 shares outstanding.
What happened to Zivo Bioscience Inc’s price movement after its last earnings report?
Zivo Bioscience Inc reported an EPS of -$1.05 in its last earnings report, expectations of -$1.05. Following the earnings report the stock price went down -0.112%.
Which hedge fund is a major shareholder of Zivo Bioscience Inc?
Currently, no hedge funds are holding shares in ZIVO
---
Zivo Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth $30.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-34.79%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-27.62%
Trailing 12-Months
Company Description
Zivo Bioscience Inc
Zivo Bioscience, Inc. is engages in the study, development and commercialization of natural nutritional compounds and bioactive molecules from its proprietary algal strains. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.
---
ZIVO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---